FAFN
ALNY icon

First Affirmative Financial Network’s Alnylam Pharmaceuticals ALNY Stock Holding History

First Affirmative Financial Network’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Buy
+809
New +$275K 0.1% 236
2025
Q3 		$247K Buy
+542
New +$221K 0.12% 223

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Affirmative Financial Network's ALNY Position: Q1 2026 in Review

First Affirmative Financial Network opened a new position in Alnylam Pharmaceuticals (ALNY) in Q1 2026: 809 shares worth $268K. The stake represents 0.1% of the portfolio and ranks #236 among its holdings. This is a return to the name: First Affirmative Financial Network previously reported a position in ALNY as recently as Q3 2025.

First Affirmative Financial Network first reported a position in ALNY in Q3 2025 and has held it in 2 quarters since. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • First Affirmative Financial Network held 809 shares of Alnylam Pharmaceuticals worth $268K as of Q1 2026.
  • Alnylam Pharmaceuticals was a new First Affirmative Financial Network position in Q1 2026.
  • Alnylam Pharmaceuticals made up 0.1% of First Affirmative Financial Network's portfolio in Q1 2026, its #236 holding.
  • First Affirmative Financial Network first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on First Affirmative Financial Network's 13F filing for Q1 2026, filed 8 May 2026.